The purpose of this study is to learn if the study medicine (PF-08049820) is safe and effective for the treatment of atopic dermatitis (AD), also known as ecze…

Atopic DermatitisEczema, Atopic

~Estimated

~$10 – $7,500

PfizerNCT07216027

Phase 2

A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

This is a phase 2b, multicenter, randomized, double-blind, placebo-controlled study.

Atopic DermatitisAtopicDermatitis+5 more

~Estimated

~$10 – $8,750

Apollo Therapeutics LtdNCT07599813

Phase 2

A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Soquelitinib in Moderate to Severe Atopic Dermatitis (SIERRA1)

The main purpose of this study is to see how well different doses of soquelitinib work in participants with atopic dermatitis (AD) as compared to a placebo (pi…

Atopic DermatitisAtopic Dermatitis EczemaEczema+1 more

~Estimated

~$10 – $8,750

Corvus Pharmaceuticals, Inc.NCT07441395